Pharmacological Properties of Hirudin and its Derivatives
- 1 March 1996
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 8 (3) , 171-182
- https://doi.org/10.2165/00002512-199608030-00003
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Antithrombotic therapy. An abbreviated reference for cliniciansArchives of internal medicine (1960), 1995
- Initial experience withhirudin andstreptokinase in acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 6 trialThe American Journal of Cardiology, 1995
- Usefulness and tolerability of Hirulog, a direct thrombin-inhibitor, in unstable angina pectorisThe American Journal of Cardiology, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Hirudins: return of the leech?The Lancet, 1992
- The Comeback of Hirudin as an Antithrombotic AgentSeminars in Thrombosis and Hemostasis, 1991
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Hirudins and the role of thrombin: lessons from leechesTrends in Pharmacological Sciences, 1988
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979